1 completed, 1 withdrawn. 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Withdrawn 1 |
Follow Brimonidine 0.2 %: new trials by email Literature Review of Brimonidine 0.2 % trials Research Report on Brimonidine 0.2 %
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate Latanoprost (Xalatan), Brimonidine 0.2 % - Glaucoma | Early Phase 1 | Completed | Zagazig University | 56 | 2024-06-24 | 2024-12-12 |
| Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor Polymorphism Brimonidine 0.2 % - Ocular Physiology, Intraocular Pressure | Not applicable | Withdrawn | Medical University of Vienna | 2008-03-01 | 2014-11-21 |
Glaucoma (1)
Medical University of Vienna (1) · Zagazig University (1)
Austria (1) · Egypt (1)